» Articles » PMID: 26109911

Chicken Chorioallantoic Membrane As a Reliable Model to Evaluate Osteosarcoma-an Experimental Approach Using SaOS2 Cell Line

Overview
Publisher Biomed Central
Date 2015 Jun 26
PMID 26109911
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Osteosarcoma is the most common primary tumor that affects usually children. Due to its cellular complex and osteoid formation it is very difficult to understand the mechanism behind the progressiveness of osteosarcoma. Various animal models are available to study the issue but they are time consuming and costly. We aimed to understand the progressiveness and invasiveness of osteosarcoma induced by SaOS2 cells using chicken chorioallantoic membrane. CAM is a well-established model which allows in vivo studies of tumor induced angiogenesis and the testing of anti angiogenic molecules. However only a few reports showed the tumor forming ability of SaOS2 cells on CAM.

Method: Angiogenic ability of SaOS2 cells on CAM was validated by various methods. Angiogenic ability was scored by direct visualization and scanning microscopic analysis. The sprouting ability and growth of the vessel was measured by Angioquant software under different cellular volume. The invasiveness was analyzed by histological staining. Involvement of angiogenic factors at differential stage of progressiveness was confirmed by the molecular and protein level expression analysis.

Result: SaOS2 cells induces sprouting angiogenesis on CAM and shows its aggressiveness by rupturing the ectodermal layer of the CAM. Growth and development of osteosarcoma depends mainly on the activation of VEGF165, MMP2 and MMP9. CAM able to reproduce angiogenic response against the stimulation of SaOS2 cells exactly as in other animal models without inflammatory reactions.

Conclusion: CAM is an excellent alternative in vivo model for studying the aggressiveness and tumor progression of osteosarcoma using various angiogenic techniques in an easily, faster and affordable way. We further provided insight about the involvement of various angiogenic growth factors on the development of osteosarcoma which will enable to find the suitable therapeutic molecule for the treatment of osteosarcoma. CAM model could provide a wide space using modern techniques like micro array or in situ hybridization to have a better understanding about the progression and invasiveness of osteosarcoma cells to develop suitable therapeutic molecules.

Citing Articles

Developing a 3D bone model of osteosarcoma to investigate cancer mechanisms and evaluate treatments.

Smith H, Beers S, Kanczler J, Gray J FASEB J. 2024; 38(24):e70274.

PMID: 39724514 PMC: 11670810. DOI: 10.1096/fj.202402011R.


Xenografting Human Musculoskeletal Sarcomas in Mice, Chick Embryo, and Zebrafish: How to Boost Translational Research.

Giusti V, Miserocchi G, Sbanchi G, Pannella M, Hattinger C, Cesari M Biomedicines. 2024; 12(8).

PMID: 39200384 PMC: 11352184. DOI: 10.3390/biomedicines12081921.


Biological Sample Collection to Advance Research and Treatment: A Fight Osteosarcoma Through European Research and Euro Ewing Consortium Statement.

Green D, Ewijk R, Tirtei E, Andreou D, Baecklund F, Baumhoer D Clin Cancer Res. 2024; 30(16):3395-3406.

PMID: 38869831 PMC: 11334773. DOI: 10.1158/1078-0432.CCR-24-0101.


High molecular weight heparin-induced angiogenesis mainly mediated via basic fibroblast growth factor-2- an (CAM) and analysis.

Manjunathan R, Mitra K, Vasvani R, Doble M Biochem Biophys Rep. 2024; 37:101609.

PMID: 38205188 PMC: 10776434. DOI: 10.1016/j.bbrep.2023.101609.


Gold Nanoparticles Inhibit Extravasation of Canine Osteosarcoma Cells in the Ex Ovo Chicken Embryo Chorioallantoic Membrane Model.

Malek A, Wojnicki M, Borkowska A, Wojcik M, Ziolek G, Lechowski R Int J Mol Sci. 2023; 24(12).

PMID: 37373007 PMC: 10297960. DOI: 10.3390/ijms24129858.


References
1.
Deryugina E, Zijlstra A, Partridge J, Kupriyanova T, Madsen M, Papagiannakopoulos T . Unexpected effect of matrix metalloproteinase down-regulation on vascular intravasation and metastasis of human fibrosarcoma cells selected in vivo for high rates of dissemination. Cancer Res. 2005; 65(23):10959-69. DOI: 10.1158/0008-5472.CAN-05-2228. View

2.
Park H, Min K, Kim H, Jung W, Park Y . Expression of vascular endothelial growth factor-C and its receptor in osteosarcomas. Pathol Res Pract. 2008; 204(8):575-82. DOI: 10.1016/j.prp.2008.01.015. View

3.
Hagedorn M, Javerzat S, Gilges D, Meyre A, de Lafarge B, Eichmann A . Accessing key steps of human tumor progression in vivo by using an avian embryo model. Proc Natl Acad Sci U S A. 2005; 102(5):1643-8. PMC: 547849. DOI: 10.1073/pnas.0408622102. View

4.
Reizis A, Hammel I, Ar A . Regional and developmental variations of blood vessel morphometry in the chick embryo chorioallantoic membrane. J Exp Biol. 2005; 208(Pt 13):2483-8. DOI: 10.1242/jeb.01662. View

5.
Kaya M, Wada T, Akatsuka T, Kawaguchi S, Nagoya S, Shindoh M . Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis. Clin Cancer Res. 2000; 6(2):572-7. View